Tissue engineering a surrogate niche for metastatic cancer cells

Biomaterials

Volumn 51, Issue , 2015, Pages 313-319

  Seib, F Philipp ^a   Berry, Janice E ^b   Shiozawa, Yusuke ^b   Taichman, Russell S ^b   Kaplan, David L ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c Tufts University   (United States)

Author keywords

Bone; Breast cancer; Cancer; Metastasis; Silk

Indexed keywords

BIOCOMPATIBILITY; BONE; CELL ENGINEERING; CELLS; CYTOLOGY; DISEASES; MAMMALS; PATHOLOGY; SILK; TISSUE; UROLOGY;

BONE MORPHOGENETIC PROTEIN-2; BREAST CANCER; CANCER; HUMAN BREAST CANCER CELLS; METASTASIS; METASTATIC CANCER CELLS; NUCLEAR FACTOR KAPPAB; TISSUE-ENGINEERED BONES;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW; BONE METASTASIS; CANCER CELL; CONTROLLED STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE ENGINEERING; TRABECULAR BONE; TUMOR GROWTH; ANIMAL; BREAST TUMOR; C57BL MOUSE; FEMALE; HUMAN; MALE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALIA; MUS;

ANIMALS; BONE MARROW; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLULAR MICROENVIRONMENT; FEMALE; HUMANS; MALE; MICE, INBRED C57BL; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TISSUE ENGINEERING;

EID: 84924861440     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.01.076     Document Type: Article

References (34)

1. Weiss L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 1992, 10:191-199.
2. Coleman R.E. Bone cancer in 2011: prevention and treatment of bone metastases. Nat Rev Clin Oncol 2012, 9:76-78.
3. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
4. Holzapfel B.M., Thibaudeau L., Hesami P., Taubenberger A., Holzapfel N.P., Mayer-Wagner S., et al. Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism. Cancer Metastasis Rev 2013, 32:129-145.
5. Pettway G.J., McCauley L.K. Ossicle and vossicle implant model systems. Methods Mol Biol 2008, 455:101-110.
6. Kyoizumi S., Baum C.M., Kaneshima H., McCune J.M., Yee E.J., Namikawa R. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 1992, 79:1704-1711.
7. Nemeth J.A., Harb J.F., Barroso U., He Z., Grignon D.J., Cher M.L. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999, 59:1987-1993.
8. Yonou H., Yokose T., Kamijo T., Kanomata N., Hasebe T., Nagai K., et al. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001, 61:2177-2182.
9. Kuperwasser C., Dessain S., Bierbaum B.E., Garnet D., Sperandio K., Gauvin G.P., et al. Amouse model of human breast cancer metastasis to human bone. Cancer Res 2005, 65:6130-6138.
10. Shtivelman E., Namikawa R. Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc Natl Acad Sci U S A 1995, 92:4661-4665.
11. Hutmacher D.W., Loessner D., Rizzi S., Kaplan D.L., Mooney D.J., Clements J.A. Can tissue engineering concepts advance tumor biology research?. Trends Biotechnol 2010, 28:125-133.
12. Lee J., Li M., Milwid J., Dunham J., Vinegoni C., Gorbatov R., et al. Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U. S. A 2012, 109:19638-19643.
13. Chan C.K., Chen C.C., Luppen C.A., Kim J.B., DeBoer A.T., Wei K., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009, 457:490-494.
14. Rosen V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 2009, 20:475-480.
15. Reddi A.H. Bone morphogenetic proteins: from basic science to clinical applications. JBone Jt Surg Am 2001, 83-A(Suppl.1):S1-S6.
16. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). JTissue Eng Regen Med 2008, 2:81-96.
17. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889, 133:571-573.
18. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
19. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002, 62:1832-1837.
20. Mishra A., Shiozawa Y., Pienta K.J., Taichman R.S. Homing of cancer cells to the bone. Cancer Microenviron 2011, 4:221-235.
21. Shiozawa Y., Pienta K.J., Taichman R.S. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res 2011, 17:5553-5558.
22. Weilbaecher K.N., Guise T.A., McCauley L.K. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011, 11:411-425.
23. Rockwood D.N., Preda R.C., Yucel T., Wang X., Lovett M.L., Kaplan D.L. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc 2011, 6:1612-1631.
24. Arguello F., Baggs R.B., Frantz C.N. Amurine model of experimental metastasis to bone and bone marrow. Cancer Res 1988, 48:6876-6881.
25. Goldstein R.H., Reagan M.R., Anderson K., Kaplan D.L., Rosenblatt M. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 2010, 70:10044-10050.
26. Seib F.P., Kaplan D.L. Doxorubicin-loaded silk films: drug-silk interactions and invivo performance in human orthotopic breast cancer. Biomaterials 2012, 33:8442-8450.
27. Kim U.J., Park J., Kim H.J., Wada M., Kaplan D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 2005, 26:2775-2785.
28. Wang Y., Rudym D.D., Walsh A., Abrahamsen L., Kim H.J., Kim H.S., et al. Invivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 2008, 29:3415-3428.
29. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 invitro and invivo. JBiomed Mater Res A 2006, 78:324-334.
30. Reddi A.H., Huggins C.B. Formation of bone marrow in fibroblast-transformation ossicles. Proc Natl Acad Sci U S A 1975, 72:2212-2216.
31. Rentala S., Mangamoori L.N. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells. JStem Cells 2010, 5:75-81.
32. Kasoju N., Bora U. Silk fibroin in tissue engineering. Adv Healthc Mater 2012, 1:393-412.
33. Omenetto F.G., Kaplan D.L. New opportunities for an ancient material. Science 2010, 329:528-531.
34. Lo Celso C., Lin C.P., Scadden D.T. Invivo imaging of transplanted hematopoietic stem and progenitor cells in mouse calvarium bone marrow. Nat Protoc 2011, 6:1-14.